Elizabeth Caldwell Zacharyasz, DPT, ATC in Belmont, NC - Medicare

Elizabeth Caldwell Zacharyasz, DPT, ATC is a medicare enrolled "Physical Therapist" physician in Belmont, North Carolina. Her current practice location is 303 Park St, Belmont, North Carolina. You can reach out to her office (for appointments etc.) via phone at (704) 829-9800.

Elizabeth Caldwell Zacharyasz is licensed to practice in North Carolina (license number P21015) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1639608292.

Contact Information

	Elizabeth Caldwell Zacharyasz, DPT, ATC
	303 Park St, Belmont, NC 28012-3367
	(704) 829-9800
	(704) 829-9810

Physician's Profile

Full Name	Elizabeth Caldwell Zacharyasz
Gender	Female
Speciality
Experience	Years
Location	303 Park St, Belmont, North Carolina
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Elizabeth Caldwell Zacharyasz attended and graduated from in

NPI Data:

NPI Number: 1639608292
Provider Enumeration Date: 06/07/2017
Last Update Date: 04/25/2022

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Elizabeth Caldwell Zacharyasz such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1639608292	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2083S0010X	Preventive Medicine - Sports Medicine	2000021399 (South Carolina)	Secondary
225100000X	Physical Therapist	P21015 (North Carolina)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Elizabeth Caldwell Zacharyasz is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Elizabeth Caldwell Zacharyasz, DPT, ATC 303 Park St, Belmont, NC 28012-3367 Ph: () -	Elizabeth Caldwell Zacharyasz, DPT, ATC 303 Park St, Belmont, NC 28012-3367 Ph: (704) 829-9800

News Archive

Boston Software Systems to host a webinar on uses and advantages of hospital workflow automation

Boston Software Systems, the leader in workflow automation technology to the healthcare market, today announced Thom Blackwell, product manager, will host a Webinar with several McKesson users on the uses and advantages of workflow automation on August 27. The Webinar is titled "Harness the Benefits of Automation in the McKesson Environment."

Arena Pharmaceuticals submits lorcaserin NDA to the FDA

Arena Pharmaceuticals, Inc. announced today that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for lorcaserin, Arena's internally discovered and developed drug candidate for weight management, including weight loss and maintenance of weight loss. The submission is based on an extensive data package from lorcaserin's clinical development program that includes 18 clinical trials totaling 8,576 patients.

Embryonic neuron transplants could effectively treat brain diseases

The unexpected survival of embryonic neurons transplanted into the brains of newborn mice in a series of experiments at the University of California, San Francisco (UCSF) raises hope for the possibility of using neuronal transplantation to treat diseases like Alzheimer's, epilepsy, Huntington's, Parkinson's and schizophrenia.

CD44 protein helps identify mother cells responsible for aggressive nature of neuroblastoma

A group of researchers from the University of Seville and the Seville Biomedicine Institute (Instituto de Biomedicina de Sevilla - IBiS) has published a study in which they determine that a protein called CD44 makes it possible to identify the population of mother cells that are responsible for the aggressive nature and low survival rate of neuroblastoma, a type of childhood cancer that mainly affects children of two and three years old.

Elizabeth Caldwell Zacharyasz, DPT, ATC - Medicare in Belmont, NC